These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Understanding the FDA's guarded system for classifying new drugs. Schneiweiss F Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828 [No Abstract] [Full Text] [Related]
6. The FDA's classification system for new drugs. An evaluation of therapeutic gain. Finkel MJ N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458 [No Abstract] [Full Text] [Related]
8. Gender differences in research. Rogers B AAOHN J; 1994 Jan; 42(1):30-2. PubMed ID: 8147983 [No Abstract] [Full Text] [Related]
9. Speeding help and hope to the desperately ill. Young FE FDA Consum; 1989 Feb; 23(1):8-9. PubMed ID: 10312854 [No Abstract] [Full Text] [Related]
10. The Food and Drug Administration's requirements for approval of new dental drugs. Gilkes CC Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180 [No Abstract] [Full Text] [Related]
11. Perspectives on the U.S. FDA Bioresearch Monitoring Program. Gamet JE Qual Assur; 1995 Mar; 4(1):12-9. PubMed ID: 8520859 [TBL] [Abstract][Full Text] [Related]
12. Strengthening the regulation of clinical trials and bioresearch monitoring. FDA Consum; 2006; 40(6):35. PubMed ID: 17333566 [TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096 [TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical trademarks: navigating through the FDA's pilot program. Ferrer E Drug News Perspect; 2010 Jun; 23(5):333-6. PubMed ID: 20603657 [TBL] [Abstract][Full Text] [Related]
15. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source. Rhea S Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431 [No Abstract] [Full Text] [Related]
16. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097 [TBL] [Abstract][Full Text] [Related]
17. The FDA's new oncology office. Pazdur R Clin Adv Hematol Oncol; 2005 Aug; 3(8):612-3. PubMed ID: 16167044 [No Abstract] [Full Text] [Related]
18. The FDA's new drug rating system. Ohio Med; 1991 Mar; 87(3):133-4. PubMed ID: 2030884 [No Abstract] [Full Text] [Related]